Navina has raised $99.0M in total across 4 funding rounds.
Navina's investors include Goldman Sachs, Grove Ventures, Vertex Ventures Israel.
Navina is a healthcare technology company that builds an AI-powered platform serving clinicians, physician groups, health systems, Accountable Care Organizations (ACOs), Managed Services Organizations (MSOs), and health plans.[1][2][5] Its core product, the Navina AI Copilot, integrates fragmented patient data from sources like electronic health records (EHRs), health information exchanges (HIEs), and claims into a unified "Patient Portrait" to support clinical decision-making, risk adjustment, quality management, and value-based care analytics at the point of care.[1][2][3][4] By alleviating administrative burdens like information overload and burnout, Navina improves risk adjustment factor (RAF) accuracy, care gap closure, HEDIS satisfaction rates, and overall outcomes, with rapid adoption—such as 90% of doctors using it within a week in some organizations—driving growth momentum.[2][5]
Founded in 2018 and headquartered in New York, New York, Navina emerged to address the chaos of fragmented patient data overwhelming clinicians amid rising value-based care demands.[1][3] Specific founders are not detailed in available sources, but the platform's development draws on physician expertise, incorporating over 600 proprietary AI algorithms shaped by clinical input to reconcile structured and unstructured data into actionable insights.[3][4] Early traction is evident from testimonials highlighting seamless EHR integration and immediate daily use by providers, positioning Navina as a clinician-first solution from the start.[2][5]
Navina rides the wave of AI-driven value-based care transformation, where shifting from fee-for-service to risk-based models demands precise data handling amid clinician burnout and data fragmentation.[1][2][3] Timing aligns with healthcare's AI adoption surge, as primary care faces financial pressures and regulatory pushes for outcomes like HEDIS and RAF accuracy, enabling providers to manage population health proactively.[2][5] Market forces favoring Navina include exploding unstructured data volumes and ACO/MSO growth, positioning it against players like Inovalon and Arcadia by prioritizing point-of-care usability over backend analytics.[1] It influences the ecosystem by empowering networks to take on more risk, boosting revenue predictability and care quality for physician-led organizations.[5]
Navina is poised for expansion as AI copilots become standard in healthcare, with potential to deepen EHR integrations and scale analytics for larger health systems amid rising value-based contracts.[2][5] Trends like ambient AI, multimodal data (e.g., adding imaging or wearables), and regulatory emphasis on explainable AI will shape its trajectory, enhancing audit-proofing and predictive capabilities.[3][4] Its influence may evolve from niche copilot to ecosystem orchestrator, further reducing burnout and driving industry-wide shifts toward proactive, data-trusted care—reinforcing its role as the clinician's essential ally in a data-overloaded era.[2][3]
Navina has raised $99.0M across 4 funding rounds. Most recently, it raised $55.0M Series C in March 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2025 | $55.0M Series C | Goldman Sachs, Grove Ventures, Vertex Ventures Israel | |
| Oct 1, 2022 | $22.0M Series B | Goldman Sachs, Grove Ventures, Vertex Ventures Israel | |
| Oct 1, 2021 | $15.0M Series A | Goldman Sachs, Grove Ventures, Vertex Ventures Israel | |
| Oct 1, 2020 | $7.0M Seed | Goldman Sachs, Grove Ventures, Vertex Ventures Israel |
